| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Feb 13, 2026 |
Vertex Pharmaceuticals, Inc.
VRTX
|
BUY |
$558.00
Est. +13%
|
$493.98 | $507.92 |
Pending
|
$450.69
-8.8%
|
| Feb 11, 2026 |
Gilead Sciences, Inc.
GILD
|
BUY |
$177.00
Est. +14%
|
$155.29 | $157.27 |
Pending
|
$124.30
-20.0%
|
| Jan 09, 2026 |
Bristol-Myers Squibb Co.
BMY
|
BUY |
$60.00
Est. +7%
|
$55.87 | $62.89 |
Target Met
|
$56.24
+0.7%
|
| Dec 04, 2025 |
Merck & Co Inc
MRK
|
BUY |
$120.00
Est. +18%
|
$101.88 | $125.14 |
Target Met
|
$114.90
+12.8%
|
| Oct 14, 2024 |
Johnson & Johnson
JNJ
|
BUY |
$215.00
Est. +33%
|
$161.60 | $194.40 |
Miss
|
$235.66
+45.8%
|
| Sep 11, 2024 |
Novo Nordisk - ADR
NVO
|
BUY |
$160.00
Est. +18%
|
$135.23 | $138.22 |
Miss
|
$43.92
-67.5%
|
| May 17, 2024 |
Abbvie Inc
ABBV
|
BUY |
$200.00
Est. +22%
|
$164.35 | $218.66 |
Target Met
|
$221.59
+34.8%
|
| Apr 30, 2024 |
Lilly(Eli) & Co
LLY
|
BUY |
$885.00
Est. +13%
|
$781.10 | $972.53 |
Target Met
|
$1,129.59
+44.6%
|
| Apr 17, 2024 |
Johnson & Johnson
JNJ
|
BUY |
$215.00
Est. +49%
|
$144.32 | $169.99 |
Miss
|
$235.66
+63.3%
|
| Feb 14, 2024 |
Pfizer Inc.
PFE
|
BUY |
$45.00
Est. +67%
|
$26.97 | $31.54 |
Miss
|
$26.00
-3.6%
|
| Sep 08, 2023 |
Atossa Therapeutics Inc
ATOS
|
BUY |
$5.00
Est. +502%
|
$0.83 | $34.65 |
Target Met
|
$2.35
+183.1%
|
| Sep 06, 2023 |
Bristol-Myers Squibb Co.
BMY
|
BUY |
$75.00
Est. +26%
|
$59.67 | $51.19 |
Miss
|
$56.24
-5.7%
|
| Aug 09, 2023 |
Lilly(Eli) & Co
LLY
|
BUY |
$630.00
Est. +20%
|
$526.40 | $966.10 |
Target Met
|
$1,129.59
+114.6%
|
| Aug 23, 2022 |
Aerie Pharmaceuticals Inc
AERI
|
BUY |
$15.25
Est. +37%
|
$11.15 | $15.25 |
Bullseye Hit (±1%)
|
$15.25
+36.8%
|
| Apr 15, 2022 |
Pfizer Inc.
PFE
|
BUY |
$75.00
Est. +41%
|
$53.12 | - | - |
$26.00
-51.1%
|
| Jan 30, 2022 |
Lilly(Eli) & Co
LLY
|
BUY |
$335.00
Est. +37%
|
$245.10 | - | - |
$1,129.59
+360.9%
|